ARTICLE | Distillery Therapeutics
Cancer
February 11, 2019 9:18 PM UTC
In vitro, cell culture and mouse studies identified a quinazolinamine-based STK19 inhibitor that could help treat NRAS-mutant melanoma. In vitro screening of a small molecule library and optimization ...